Free provider profile
REMIGIUSZ DROZD, D.O.
Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2023-06-08.
331 N MILPAS ST STE 1B, SANTA BARBARA, CA, 93103
805-694-1311
Single practice location
Enumerated 2009-04-29
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — Record last updated 3 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
69
Medicare patients
16
Part D drug cost
$99,870
Brand-name share
75.4%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Spravato (Esketamine Hcl) | 52 | $99,638 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
2024143 sessions · 18 patients · $159,030
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.